IL145524A0 - Formulation comprising testosterone undecanoate and castor oil - Google Patents
Formulation comprising testosterone undecanoate and castor oilInfo
- Publication number
- IL145524A0 IL145524A0 IL14552400A IL14552400A IL145524A0 IL 145524 A0 IL145524 A0 IL 145524A0 IL 14552400 A IL14552400 A IL 14552400A IL 14552400 A IL14552400 A IL 14552400A IL 145524 A0 IL145524 A0 IL 145524A0
- Authority
- IL
- Israel
- Prior art keywords
- castor oil
- testosterone undecanoate
- solution
- liquid carrier
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Fats And Perfumes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99302581 | 1999-04-01 | ||
| PCT/EP2000/002677 WO2000059512A1 (en) | 1999-04-01 | 2000-03-27 | Formulation comprising testosteron undecanoate and castor oil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL145524A0 true IL145524A0 (en) | 2002-06-30 |
Family
ID=8241306
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14552400A IL145524A0 (en) | 1999-04-01 | 2000-03-27 | Formulation comprising testosterone undecanoate and castor oil |
| IL145524A IL145524A (en) | 1999-04-01 | 2001-09-20 | Compositions containing testosterone undecanoate and castor oil |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL145524A IL145524A (en) | 1999-04-01 | 2001-09-20 | Compositions containing testosterone undecanoate and castor oil |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP1189620B1 (de) |
| JP (1) | JP2002541111A (de) |
| KR (1) | KR100666016B1 (de) |
| CN (1) | CN1155385C (de) |
| AT (1) | ATE269708T1 (de) |
| AU (1) | AU768537B2 (de) |
| BR (1) | BR0009465A (de) |
| CA (1) | CA2366856C (de) |
| CZ (1) | CZ298573B6 (de) |
| DE (1) | DE60011771T2 (de) |
| DK (1) | DK1189620T3 (de) |
| ES (1) | ES2222199T3 (de) |
| HK (1) | HK1043544A1 (de) |
| HU (1) | HU229455B1 (de) |
| ID (1) | ID30481A (de) |
| IL (2) | IL145524A0 (de) |
| MX (1) | MXPA01009919A (de) |
| NO (1) | NO329420B1 (de) |
| NZ (1) | NZ514290A (de) |
| PL (1) | PL195163B1 (de) |
| PT (1) | PT1189620E (de) |
| RU (1) | RU2246296C2 (de) |
| SK (1) | SK286071B6 (de) |
| TR (1) | TR200102769T2 (de) |
| TW (1) | TWI280124B (de) |
| WO (1) | WO2000059512A1 (de) |
| ZA (1) | ZA200107781B (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6652880B1 (en) | 1999-04-01 | 2003-11-25 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants |
| GB9907715D0 (en) * | 1999-04-01 | 1999-05-26 | Scherer Corp R P | Pharmaceutical compositions |
| JO2505B1 (en) * | 2003-03-14 | 2009-10-05 | باير شيرنغ فارما اكتنجيسيلشافت | Pharmacy methods and formulations for obtaining acceptable serum testosterone levels |
| ES2258694T3 (es) | 2003-11-11 | 2006-09-01 | Mattern, Udo | Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales. |
| US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
| US20060140820A1 (en) | 2004-12-28 | 2006-06-29 | Udo Mattern | Use of a container of an inorganic additive containing plastic material |
| RU2429850C2 (ru) | 2005-04-15 | 2011-09-27 | Кларус Терапьютикс, Инк. | Фармацевтические системы доставки для гидрофобных лекарственных средств и композиций, их содержащих |
| US8492369B2 (en) | 2010-04-12 | 2013-07-23 | Clarus Therapeutics Inc | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
| DK2068825T3 (da) | 2006-10-04 | 2011-05-16 | M & P Patent Ag | Kontrolleret frisætningstilførselssystem til nasal påføring af neurotransmittere |
| GB0818473D0 (en) | 2008-10-08 | 2008-11-12 | Probio Nutraceuticals As | Composition |
| US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
| ES2525520T3 (es) * | 2010-04-12 | 2014-12-26 | Clarus Therapeutics, Inc. | Formulaciones orales de éster de testosterona y métodos para tratar la deficiencia de testosterona con las mismas |
| GB201006200D0 (en) * | 2010-04-14 | 2010-06-02 | Ayanda As | Composition |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| RU2599036C2 (ru) * | 2011-01-26 | 2016-10-10 | Аллерган, Инк. | Андрогенная композиция для лечения офтальмологического заболевания |
| US20130045958A1 (en) | 2011-05-13 | 2013-02-21 | Trimel Pharmaceuticals Corporation | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
| US20130040923A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
| BR112016028192A2 (pt) | 2014-06-17 | 2017-08-22 | Merck Sharp & Dohme | gerritdina g. schoonus-gerritsma |
| ES2851332T3 (es) * | 2014-06-19 | 2021-09-06 | Solural Pharma ApS | Forma sólida de dosificación oral de compuestos lipofílicos |
| US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
| US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
| RU2017111503A (ru) * | 2014-08-29 | 2018-10-05 | Липосин Инк. | КОМПОЗИЦИИ(17-β)-3-ОКСОАНДРОСТ-4-ЕН-17-ИЛ УНДЕКАНОАТА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ |
| EP3544614A4 (de) | 2016-11-28 | 2020-08-05 | Lipocine Inc. | Orale testosteron-undecanoat-therapie |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1102095A (zh) * | 1993-10-30 | 1995-05-03 | 浙江医科大学 | 长效雄激素类制剂——十一酸睾丸注射液 |
| GB9608719D0 (en) * | 1996-04-26 | 1996-07-03 | Scherer Ltd R P | Pharmaceutical compositions |
| SE9700642D0 (sv) * | 1997-02-24 | 1997-02-24 | Kronvall Stefan Med Ab | Medel och sätt för förebyggande och behandling av det metabola syndromet |
-
2000
- 2000-03-27 WO PCT/EP2000/002677 patent/WO2000059512A1/en active IP Right Grant
- 2000-03-27 BR BR0009465-0A patent/BR0009465A/pt not_active Application Discontinuation
- 2000-03-27 DK DK00920588T patent/DK1189620T3/da active
- 2000-03-27 NZ NZ514290A patent/NZ514290A/en not_active IP Right Cessation
- 2000-03-27 SK SK1372-2001A patent/SK286071B6/sk not_active IP Right Cessation
- 2000-03-27 IL IL14552400A patent/IL145524A0/xx active IP Right Grant
- 2000-03-27 EP EP00920588A patent/EP1189620B1/de not_active Expired - Lifetime
- 2000-03-27 TR TR2001/02769T patent/TR200102769T2/xx unknown
- 2000-03-27 DE DE60011771T patent/DE60011771T2/de not_active Expired - Lifetime
- 2000-03-27 PT PT00920588T patent/PT1189620E/pt unknown
- 2000-03-27 CN CNB008059381A patent/CN1155385C/zh not_active Expired - Lifetime
- 2000-03-27 AU AU41111/00A patent/AU768537B2/en not_active Expired
- 2000-03-27 JP JP2000609075A patent/JP2002541111A/ja not_active Withdrawn
- 2000-03-27 RU RU2001129362/15A patent/RU2246296C2/ru active
- 2000-03-27 AT AT00920588T patent/ATE269708T1/de active
- 2000-03-27 CZ CZ20013507A patent/CZ298573B6/cs not_active IP Right Cessation
- 2000-03-27 PL PL00351259A patent/PL195163B1/pl unknown
- 2000-03-27 HU HU0200453A patent/HU229455B1/hu unknown
- 2000-03-27 KR KR1020017012498A patent/KR100666016B1/ko active IP Right Grant
- 2000-03-27 ID IDW00200102082A patent/ID30481A/id unknown
- 2000-03-27 MX MXPA01009919A patent/MXPA01009919A/es active IP Right Grant
- 2000-03-27 ES ES00920588T patent/ES2222199T3/es not_active Expired - Lifetime
- 2000-03-27 CA CA002366856A patent/CA2366856C/en not_active Expired - Lifetime
- 2000-05-11 TW TW089109036A patent/TWI280124B/zh not_active IP Right Cessation
-
2001
- 2001-09-20 IL IL145524A patent/IL145524A/en not_active IP Right Cessation
- 2001-09-20 ZA ZA200107781A patent/ZA200107781B/en unknown
- 2001-09-28 NO NO20014718A patent/NO329420B1/no not_active IP Right Cessation
-
2002
- 2002-07-17 HK HK02105288A patent/HK1043544A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL145524A0 (en) | Formulation comprising testosterone undecanoate and castor oil | |
| RU2001129362A (ru) | Композиция, включающая ундеканоат тестостерона и касторовое масло | |
| GB9907715D0 (en) | Pharmaceutical compositions | |
| CA2185347A1 (en) | A carrier for hydrophobic drugs and a pharmaceutical composition based thereon | |
| PL318560A1 (en) | Novel orally administered preparations containing cyclosporin of simple composition and high bioavailability | |
| EP0904064A1 (de) | Orale pharmazeutische zusammensetzungen mit sexualhormonen | |
| CA2301017A1 (en) | Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds | |
| US20050287203A1 (en) | Formulation comprising testosteron undecanoate and castor oil | |
| CA2431397A1 (en) | Self emulsifying lipid matrix (selm) | |
| NO950134L (no) | Formuleringer for oralt administrerte farmasöytiske midler | |
| MXPA05008921A (es) | Formulaciones orales semisolidas para liberacion inmediata que comprenden un agente hidrofobo anticancer, un glicerido poliglicolisado y un vehiculo hidrofilo. | |
| AR023235A1 (es) | Formulaciones de androgenos | |
| AU3043400A (en) | Cyclosporin solution | |
| US20060024341A1 (en) | Microemulsion composition and related method | |
| TH33003B (th) | สูตรตำรับแอนโดรเจน | |
| TH60756A (th) | สูตรตำรับแอนโดรเจน | |
| TH34374B (th) | องค์ประกอบเชิงเภสัชกรรมชนิดที่เป็นของแข็งซึ่งประกอบด้วยอนุพันธ์เบนโซฟูแรน | |
| TH40043A (th) | องค์ประกอบเชิงเภสัชกรรมชนิดที่เป็นของแข็งซึ่งประกอบด้วยอนุพันธ์เบนโซฟูแรน | |
| MY130474A (en) | Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants | |
| MXPA99006916A (en) | Oil-free pharmaceutical compositions containing cyclosporin a |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |